Universe Pharmaceuticals, Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: KYG9442G1120

USD

4.18

0.06 (1.46%)

Dec 05

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Evoke Pharma, Inc.

Bellerophon Therapeutics, Inc.

Jaguar Health, Inc.

SeqLL, Inc.

Hoth Therapeutics, Inc.

Cyclacel Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc.

Artelo Biosciences, Inc.

CNS Pharmaceuticals, Inc.

ZyVersa Therapeutics, Inc.

Universe Pharmaceuticals, Inc.

Why is Universe Pharmaceuticals, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Universe Pharmaceuticals, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Universe Pharmaceuticals, Inc.

-90.05%

-0.02

4911.25%

S&P 500

12.66%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-13.58%

EBIT Growth (5y)

-6.56%

EBIT to Interest (avg)

-0.01

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.72

Sales to Capital Employed (avg)

3.18

Tax Ratio

3.15%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

2.87%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.05

EV to EBIT

-0.49

EV to EBITDA

-0.36

EV to Capital Employed

-0.80

EV to Sales

-0.12

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-1055.87%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Universe Pharmaceuticals, Inc.

Operating Cash Flow - Annually

Highest at USD 1.16 MM and Grown

each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Here's what is not working for Universe Pharmaceuticals, Inc.

Profit After Tax (PAT) - Annual

At USD -6.16 MM has Grown at -19.52 %

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very negative

PAT (USD MM)

Net Sales - Half-Yearly

At USD 14 MM has Fallen at -13.17 %

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Net Sales - Half-Yearly

Lowest at USD 14 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Cash and Cash Equivalents - Half Yearly

Lowest at USD 5.29 MM

in the last six half yearly periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents (USD MM)